Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (251-260 of 721) with videos related to

Pageof 73
Sort By:
Molecular Imaging and Biology|May 8, 2010
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junctionSylvie Lorenzen, Ben Panzram, Gisela Keller, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging groupNandita M deSouza, Yan Liu, Arturo Chiti, et al.
Journal of Clinical Medicine|February 10, 2024
Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red FlagsAiste Monika Jakstaite, Julia Kirsten Vogel, Peter Luedike, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary ResultsMichal Chodyla, Francesco Barbato, Uta Dirksen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2016
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging AgentHiroshi Wakabayashi, Rudolf A Werner, Nobuyuki Hayakawa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2017
Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trialYoussef Erfanian, Johannes Grueneisen, Julian Kirchner, et al.
Seminars in Nuclear Medicine|December 3, 2023
What Role Does PET/MRI Play in Musculoskeletal Disorders?Tugce Telli, Mélanie Desaulniers, Thomas Pyka, et al.
Oncology Letters|March 7, 2025
[<sup>68</sup>Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between meningioma and glioblastoma: A case report and review of the literatureLaurèl Rauschenbach, Felix M Gerach, Christoph Berliner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2017
Comparison of <sup>18</sup>F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervixTheresia Sarabhai, Benedikt M Schaarschmidt, Axel Wetter, et al.
Cancers|September 10, 2021
Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter TrialPhilipp Seifert, Simone Schenke, Michael Zimny, et al.
Pageof 73

Showing results (251-260 of 721) with videos related to

Sort By:
Pageof 73
Molecular Imaging and Biology|May 8, 2010
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junctionSylvie Lorenzen, Ben Panzram, Gisela Keller, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging groupNandita M deSouza, Yan Liu, Arturo Chiti, et al.
Journal of Clinical Medicine|February 10, 2024
Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red FlagsAiste Monika Jakstaite, Julia Kirsten Vogel, Peter Luedike, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary ResultsMichal Chodyla, Francesco Barbato, Uta Dirksen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2016
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging AgentHiroshi Wakabayashi, Rudolf A Werner, Nobuyuki Hayakawa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2017
Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trialYoussef Erfanian, Johannes Grueneisen, Julian Kirchner, et al.
Seminars in Nuclear Medicine|December 3, 2023
What Role Does PET/MRI Play in Musculoskeletal Disorders?Tugce Telli, Mélanie Desaulniers, Thomas Pyka, et al.
Oncology Letters|March 7, 2025
[<sup>68</sup>Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between meningioma and glioblastoma: A case report and review of the literatureLaurèl Rauschenbach, Felix M Gerach, Christoph Berliner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2017
Comparison of <sup>18</sup>F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervixTheresia Sarabhai, Benedikt M Schaarschmidt, Axel Wetter, et al.
Cancers|September 10, 2021
Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter TrialPhilipp Seifert, Simone Schenke, Michael Zimny, et al.
Pageof 73